Check Before You Invest : Healthcare Global Enterprises Ltd

Q: Which industry/sub-sector does Healthcare Global Enterprises Ltd belong to?

Healthcare Global Enterprises Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.

Q: Is Healthcare Global Enterprises Ltd a good quality company?

Healthcare Global Enterprises Ltd is a average quality company, based on a somewhat consistent multi-year financial track record. This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

Q: Is Healthcare Global Enterprises Ltd undervalued or overvalued?

Healthcare Global Enterprises Ltd appears Overvalued, as its key valuation ratios are higher than their past averages. Based on the industry it operates in, the relevant valuation ratios include one of the following, P/E, P/BV, P/Sales, EV/EBITDA or a combination of two or more. Valuation Ratios. Price to Earnings, Current: 389.44, Historic Median: 99.25. Price to Book, Current: 5.62, Historic Median: 4.15. Price to Sales, Current: 6.75, Historic Median: 4.67. EV to EBITDA, Current: 37.98, Historic Median: 26.43

Q: Is Healthcare Global Enterprises Ltd a good buy now?

Healthcare Global Enterprises Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Q: Revenue growth of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd revenue growth is 9% for FY-2025, which is below its 5-year CAGR of 13.15%, indicating slower growth.

Q: Gross Profit margin of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd Gross profit margin which is the profit after deduction of direct costs, is 13% for FY-2025, which is below its 5-year median of 13.7%, indicating decreasing margins.

Q: Operating Profit Margin of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 16.56% for FY-2025, which is in line with its 5-year median of 16.93% indicating stable margins.

Q: Net Profit Margin of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd Net Profit Margin is 0.28% for FY-2025, is below its 5-year median of 2.8%, indicating decreasing margins. Profitability Metrics. Gross Profit Margin (%), Current: 13, Historic Median: 13.7. Operating Profit Margin (%), Current: 16.56, Historic Median: 16.93. Net Profit Margin (%), Current: 0.28, Historic Median: 2.8

Q: Return on Asset of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd Return on Asset is 0.15%, which is below its 5-year historical median of 1.65%, indicating deteriorated asset utilization efficiency.

Q: Return on capital employed (ROCE) of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd Return on capital employed is 6.03% for FY-2025, which is below its 5-year historical median of 7.25%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 13.5%, indicating value preservation.

Check Before You Invest : Healthcare Global Enterprises Ltd

Snapshot

Q.1 Which industry/sub-sector does Healthcare Global Enterprises Ltd belong to?

Healthcare Global Enterprises Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.

Q.2 Is Healthcare Global Enterprises Ltd a good quality company?

Healthcare Global Enterprises Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

Q.3 Is Healthcare Global Enterprises Ltd undervalued or overvalued?

Healthcare Global Enterprises Ltd appears Overvalued, as its key valuation ratios are higher than their past averages.

Based on the industry it operates in, the relevant valuation ratios include one of the following, P/E, P/BV, P/Sales, EV/EBITDA or a combination of two or more.

Valuation Ratios	Current	5-year Historic Median
Price to Earnings	389.44	99.25
Price to Book	5.62	4.15
Price to Sales	6.75	4.67
EV to EBITDA	37.98	26.43

Q.4 Is Healthcare Global Enterprises Ltd a good buy now?

Healthcare Global Enterprises Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Performance Analysis

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

A: What are the trends in revenue and profit margins?

Q.1 Revenue growth of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd revenue growth is 9% for FY-2025, which is below its 5-year CAGR of 13.15%, indicating slower growth.

Q.2 Gross Profit margin of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd Gross profit margin which is the profit after deduction of direct costs, is 13% for FY-2025, which is below its 5-year median of 13.7%, indicating decreasing margins.

Q.3 Operating Profit Margin of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 16.56% for FY-2025, which is in line with its 5-year median of 16.93% indicating stable margins.

Q.4 Net Profit Margin of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd Net Profit Margin is 0.28% for FY-2025, is below its 5-year median of 2.8%, indicating decreasing margins.

	Current Level	5-year Historic Median
Gross Profit Margin (%)	13	13.7
Operating Profit Margin (%)	16.56	16.93
Net Profit Margin (%)	0.28	2.8

B: Does the business utilize capital efficiently?

Q.5 Return on Asset of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd Return on Asset is 0.15%, which is below its 5-year historical median of 1.65%, indicating deteriorated asset utilization efficiency.

Q.6 Return on capital employed (ROCE) of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd Return on capital employed is 6.03% for FY-2025, which is below its 5-year historical median of 7.25%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 13.5%, indicating value preservation.

Q.7 Return on Equity (ROE) of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd Return on equity is 0.3% for FY-2025, which is below its 5-year historical median of 2.86%, indicating the business is making worse use of its shareholders capital.

Q.8 Cash conversion cycle of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd Cash conversion cycle is 21 days, below its 5-year historical median of 26 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.

	Current Level	5-year Historic Median
Asset Turnover (x)	0.53	0.53
ROE (%)	0.3	2.86
ROCE (%)	6.03	7.25
Cash Conversion Cycle	21 days	26 days

C: How much debt does the business have and is it at a sustainable level?

Q.9 Debt to Equity ratio of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd Debt-to-Equity ratio is 0.56, which is above the industry average of 0.20, indicating higher debt levels in the industry.

Q.10 Debt to cash flow from operations of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd Debt to cash flow from operations is 4.46, which is at a unhealthy level.

Ownership & governance

D: Promoter shareholding and pledge status of Healthcare Global Enterprises Ltd?

Q.1 Promoter shareholding and pledge status of Healthcare Global Enterprises Ltd?

Promoters hold 64.21% of the Healthcare Global Enterprises Ltd, with 5.17% of their stake pledged, indicating low pledge risk.

Peer comparison (industry-wise, mcap)

E: How does Healthcare Global Enterprises Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Healthcare Global Enterprises Ltd vs industry peers?

Healthcare Global Enterprises Ltd revenue CAGR is 13.15%, compared to the industry median CAGR of 1.38%, indicating faster growth and gaining its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth (%)	9	1.4
Gross Profit Growth (%)	-0.6	18.5
Operating Profit Growth (%)	5	15.4
Net Profit Growth (%)	-87.9	23.7

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover (x)	0.53	0.73
ROE (%)	0.3	13.88
ROCE (%)	6.03	17.77
Cash Conversion Cycle (days)	20.71	1

Valuation & price assessment

Q.1 Stock return of Healthcare Global Enterprises Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 13% based on the current price.

	9Y	5Y	3Y	1Y
Share Price CAGR	13%	26.1%	31%	10.8%

Q.2 Valuation ratios of Healthcare Global Enterprises Ltd vs historical?

The current P/E ratio of 389.44 is higher than its historical median of 99.25, indicating that the stock is trading above its historical average valuation.

Q.3 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	389.44	99.25	37.25
Price to Book	5.62	4.15	3.64
Price to Sales	6.75	4.67	4.21
EV to EBITDA	37.98	26.43	17.66

Check more companies

1. Aster DM Healthcare

2. Global Health

3. Krishna Inst.Medi

4. Dr. Lal Pathlabs

5. Dr. Agarwals Health

6. RainbowChildrenS Med

7. Vijaya Diagnostic

8. Metropolis Health.

9. Park Medi World

10. HealthcareGlobal

Check trending companies

1. GE Vernova T&D India Ltd.

2. Pidilite Industries Ltd.

3. Birlasoft Ltd.

4. Gabriel India Ltd.

5. Rail Vikas Nigam Ltd.

Check Before You Invest : Healthcare Global Enterprises Ltd

Snapshot

Performance Analysis

Ownership & governance

Peer comparison (industry-wise, mcap)

Profit Metrics

Operating Efficiency

Valuation & price assessment

Check more companies

Check trending companies

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.